Inge is a clinical trialist having nearly 30 years of experience in the biopharmaceutical industry, with cross-functional leadership in drug development from IND-enabling studies through NDA filings. Prior to joining, she was the V.P. of Clinical Operations & Development at La Jolla Pharmaceutical Company, where she played a pivotal role in the development and subsequent FDA approval of Giapreza™. Inge has held previous operational and development roles at Kalypsys, Ambrx, CovX Research, INC Research, MediGene, Vical, and Quintiles. She holds a master’s degree in physiology, and a bachelor’s degree from UC Berkeley.